Hepatitis B trials in New Zealand

In New Zealand 8 Also abroad 192

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
Where
Grafton
Age
18 years to 65 years
People
84 worldwide
Run by
AusperBio Therapeutics Inc.
See details and how to joinNCT07370207
Phase 1Taking people
A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
Where
Auckland
Age
18 years to 70 years
People
88 worldwide
Run by
IntegerBio
See details and how to joinNCT07389044
Phase 1Taking people
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
Where
Auckland
Age
18 years to 70 years
People
45 worldwide
Run by
Precision BioSciences, Inc.
See details and how to joinNCT06680232 · EU 2025-524157-13-00
Phase 1/2Taking people
A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
Where
Auckland
Age
18 years to 64 years
People
66 worldwide
Run by
nChroma Bio
See details and how to joinNCT07200193 · EU 2025-523619-12-00
Phase 1Not yet taking people in New Zealand
Study of AHB-171 in Chronic Hepatitis B Participants
Where
Grafton
Age
18 years to 65 years
People
144 worldwide
Run by
AusperBio Therapeutics Inc.
See details and how to joinNCT07617194
No phaseEnrolling by invitation
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Where
Auckland
Age
19 years to 80 years
People
45 worldwide
Run by
Precision BioSciences, Inc.
See details and how to joinNCT07254208
Phase 1Taking people
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Where
Auckland
Age
18 years to 75 years
People
36 worldwide
Run by
Tune Therapeutics, Inc.
See details and how to joinNCT06671093
Phase 1Not yet taking people in New Zealand
Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
Where
Christchurch, Grafton
Age
18 years to 65 years
People
36 worldwide
Run by
Epigenic Therapeutics, Inc
See details and how to joinNCT06661148